Medeon Biodesign Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	419.43	292.81	196.26	298.32	68.96
Revenue Growth (YoY)	43.24%	49.19%	-34.21%	332.61%	-43.96%
Cost of Revenue	360.6	209.39	181.89	111.51	40.33
Gross Profit	58.83	83.41	14.38	186.81	28.63
Selling, General & Admin	194.08	203.75	185.91	153.03	108.35
Research & Development	587.19	751.87	667.46	521.62	415.87
Operating Expenses	781.34	969.03	853.94	674.65	524.22
Operating Income	-722.51	-885.61	-839.57	-487.84	-495.59
Interest Expense	-3.68	-5.56	-6.64	-5.21	-1.03
Interest & Investment Income	7.19	20.17	19.94	10.29	6.12
Earnings From Equity Investments	-	-	13.54	47.69	19.66
Currency Exchange Gain (Loss)	-2.6	14.43	-6.19	15.35	-
Other Non Operating Income (Expenses)	0.19	0.2	0.39	0.34	-43.07
EBT Excluding Unusual Items	-721.42	-856.37	-818.53	-419.38	-513.91
Gain (Loss) on Sale of Investments	1.72	-2.28	-399.15	-19.73	-
Gain (Loss) on Sale of Assets	-	-	-13.01	-	-
Pretax Income	-719.69	-858.64	-1,231	-439.12	-513.91
Income Tax Expense	-0.35	11.88	39.29	57.79	72.46
Earnings From Continuing Operations	-719.34	-870.52	-1,270	-496.9	-586.36
Earnings From Discontinued Operations	-	-	-	-	2,618
Net Income to Company	-719.34	-870.52	-1,270	-496.9	2,031
Minority Interest in Earnings	51.28	65.01	65.36	63.14	46.75
Net Income	-668.06	-805.51	-1,205	-433.76	2,078
Net Income to Common	-668.06	-805.51	-1,205	-433.76	2,078
Shares Outstanding (Basic)	92	92	92	92	92
Shares Outstanding (Diluted)	92	92	92	92	92
Shares Change (YoY)	0.21%	0.11%	0.02%	-0.07%	0.48%
EPS (Basic)	-7.24	-8.74	-13.09	-4.71	22.65
EPS (Diluted)	-7.24	-8.74	-13.09	-4.71	22.65
Free Cash Flow	-645.61	-906.97	-810.36	-601.91	-301.69
Free Cash Flow Per Share	-6.99	-9.84	-8.80	-6.54	-3.28
Dividend Per Share	-	-	-	0.476	0.794
Dividend Growth	-	-	-	-40.00%	-
Gross Margin	14.03%	28.49%	7.32%	62.62%	41.52%
Operating Margin	-172.26%	-302.45%	-427.78%	-163.53%	-718.69%
Profit Margin	-159.28%	-275.10%	-613.78%	-145.40%	3013.75%
Free Cash Flow Margin	-153.93%	-309.75%	-412.90%	-201.77%	-437.51%
EBITDA	-666.44	-839.21	-797.3	-459.64	-463.09
EBITDA Margin	-158.89%	-286.61%	-	-154.08%	-
D&A For EBITDA	56.08	46.4	42.26	28.2	32.5
EBIT	-722.51	-885.61	-839.57	-487.84	-495.59
EBIT Margin	-172.26%	-	-	-163.53%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.